Walvax BioTech (300142) — Cash Flow-to-Debt Ratio
Walvax BioTech (300142) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of CN¥-33.52 Million could theoretically repay 0% of its total liabilities (CN¥2.31 Billion) in one year. Explore investment intensity of Walvax BioTech to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Walvax BioTech Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Walvax BioTech across 19 annual periods. Also explore total assets of Walvax BioTech for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Walvax BioTech (2007–2025)
Year-by-year debt coverage analysis for Walvax BioTech. For market capitalisation and broader financial context, see Walvax BioTech stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥494.37 Million | CN¥2.26 Billion | ▼ -32.0% |
| 2024 | 0.32x | CN¥1.04 Billion | CN¥3.22 Billion | ▲ +19.2% |
| 2023 | 0.27x | CN¥1.13 Billion | CN¥4.19 Billion | ▼ -2.2% |
| 2022 | 0.28x | CN¥1.20 Billion | CN¥4.35 Billion | ▲ +44.1% |
| 2021 | 0.19x | CN¥705.28 Million | CN¥3.68 Billion | ▲ +202.5% |
| 2020 | 0.06x | CN¥114.19 Million | CN¥1.80 Billion | ▲ +38.3% |
| 2019 | 0.05x | CN¥62.02 Million | CN¥1.35 Billion | ▲ +239.5% |
| 2018 | -0.03x | CN¥-65.23 Million | CN¥1.98 Billion | ▼ -653.0% |
| 2017 | 0.00x | CN¥-10.13 Million | CN¥2.32 Billion | ▲ +86.4% |
| 2016 | -0.03x | CN¥-89.94 Million | CN¥2.80 Billion | ▼ -49.6% |
| 2015 | -0.02x | CN¥-69.41 Million | CN¥3.23 Billion | ▲ +10.3% |
| 2014 | -0.02x | CN¥-65.93 Million | CN¥2.76 Billion | ▲ +37.2% |
| 2013 | -0.04x | CN¥-121.73 Million | CN¥3.20 Billion | ▼ -162.2% |
| 2012 | 0.06x | CN¥78.38 Million | CN¥1.28 Billion | ▼ -80.5% |
| 2011 | 0.31x | CN¥91.98 Million | CN¥293.62 Million | ▲ +57.3% |
| 2010 | 0.20x | CN¥86.71 Million | CN¥435.52 Million | ▼ -48.8% |
| 2009 | 0.39x | CN¥82.18 Million | CN¥211.43 Million | ▲ +1489.3% |
| 2008 | -0.03x | CN¥-5.69 Million | CN¥203.54 Million | ▼ -117.6% |
| 2007 | 0.16x | CN¥31.85 Million | CN¥199.86 Million | — |